Orserdu 345 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9JW3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,041
Award facts
- Contract value 100% obligated
- $27,041.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,041.46 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Orserdu 345 mg tablets in quantities of 30. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed by January 28, 2026, with fulfillment occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
The underlying indefinite delivery vehicle serves as a comprehensive global pharmaceutical support contract enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to military healthcare programs and affiliated federal agencies worldwide. AmerisourceBergen's significant presence in federal pharmaceutical procurement, evidenced by its extensive portfolio of medical product deliveries and competitive positioning, supports the Defense Health Agency and other government healthcare systems. This particular task order for Orserdu, an oncology medication, reflects the contractor's role in supplying critical specialty pharmaceuticals to the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9JW3?
SPE2DR26F9JW3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9JW3 worth?
The government has obligated $27,041 on SPE2DR26F9JW3.
Is contract SPE2DR26F9JW3 an order under another contract?
Yes. SPE2DR26F9JW3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JW3 competed?
The extent of competition for SPE2DR26F9JW3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award